Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/25/24 17:41 | 3/25/24 | MIRM | Health | Drug | Pharmaceutical Preparations | Radovich Peter | CA | O | P,COO | 2 | S | -139 | 24.54 | 0 | -6 | 33 | D | |||||||||||||||
3/18/24 17:44 | 1/9/23 | MIRM | Health | Drug | Pharmaceutical Preparations | Vig Pamela | CA | O | Chief Sc | 1 | S | -28 | 20.62 | 0 | -1 | 102 | D | |||||||||||||||
3/18/24 17:40 | 1/9/23 | MIRM | Health | Drug | Pharmaceutical Preparations | Longpre Lara | CA | O | Chief De | 1 | S | -21 | 20.62 | 0 | -1 | 104 | D | |||||||||||||||
3/18/24 17:37 | 1/9/23 | MIRM | Health | Drug | Pharmaceutical Preparations | Peetz Christopher | CA | DO | CEO | 1 | S | -106 | 20.62 | 0 | -5 | 301 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |